| scholarly article | Q13442814 |
| P356 | DOI | 10.1007/978-3-319-22822-8_4 |
| P698 | PubMed publication ID | 26424643 |
| P2093 | author name string | Paul J Farrell | |
| P2860 | cites work | Specific latent membrane protein 1 gene sequences in type 1 and type 2 Epstein-Barr virus from nasopharyngeal carcinoma in Hong Kong. | Q45756231 |
| Epstein-Barr virus strain variation in nasopharyngeal carcinoma from the endemic and non-endemic regions of China | Q45756839 | ||
| BHRF1, a viral homologue of the Bcl-2 oncogene, is conserved at both the sequence and functional level in different Epstein-Barr virus isolates | Q45759513 | ||
| Sequence variation in the Epstein-Barr virus latent membrane protein 1. | Q45782895 | ||
| Sequence polymorphism in the Epstein-Barr virus latent membrane protein (LMP)-2 gene. | Q45784236 | ||
| DNA of Epstein-Barr virus VIII: B95-8, the previous prototype, is an unusual deletion derivative | Q45803144 | ||
| A putative transforming gene of Jijoye virus differs from that of Epstein-Barr virus prototypes | Q45837523 | ||
| Sequence analysis of Raji Epstein-Barr virus DNA. | Q45841555 | ||
| New BZLF1 sequence variations in EBV-associated undifferentiated nasopharyngeal carcinoma in southern China | Q46378710 | ||
| High frequency of EBV association and 30-bp deletion in the LMP-1 gene in CD56 lymphomas of the upper aerodigestive tract | Q48025040 | ||
| Characterization of variants in the promoter of EBV gene BZLF1 in normal donors, HIV-positive patients and in AIDS-related lymphomas. | Q51939527 | ||
| Genetic variations of EBV-LMP1 from nasopharyngeal carcinoma biopsies: potential loss of T cell epitopes. | Q54545163 | ||
| Sequence polymorphisms between latent membrane proteins LMP1 and LMP2A do not correlate in EBV-associated reactive and malignant lympho-proliferations | Q77345741 | ||
| The 30-bp deletion variant: a polymorphism of latent membrane protein 1 prevalent in endemic and non-endemic areas of nasopharyngeal carcinomas in China | Q77486698 | ||
| Detection of different clonal EBV strains in Hodgkin lymphoma and nasopharyngeal carcinoma tissues from the same patient | Q81113979 | ||
| Analysis of LMP1 variants of EBV in Southern Thailand: evidence for strain-associated T-cell tropism and pathogenicity | Q83158176 | ||
| The nucleotide polymorphisms within the Epstein-Barr virus C and Q promoters from nasopharyngeal carcinoma affect transcriptional activity in vitro | Q45361246 | ||
| Characterization of Epstein-Barr virus gp350/220 gene variants in virus isolates from gastric carcinoma and nasopharyngeal carcinoma | Q45362064 | ||
| Epstein-Barr virus genome polymorphisms of Epstein-Barr virus-associated gastric carcinoma in gastric remnant carcinoma in Guangzhou, southern China, an endemic area of nasopharyngeal carcinoma | Q45365278 | ||
| Sequence variation of Epstein-Barr virus (EBV) BZLF1 gene in EBV-associated gastric carcinomas and nasopharyngeal carcinomas in Northern China | Q45367015 | ||
| Widespread sequence variation in the Epstein-Barr virus latent membrane protein 2A gene among northern Chinese isolates | Q45375222 | ||
| New variations of Epstein-Barr virus-encoded small RNA genes in nasopharyngeal carcinomas, gastric carcinomas, and healthy donors in northern China | Q45377303 | ||
| Association of distinctive Epstein-Barr virus variants with gastric carcinoma in Guangzhou, southern China | Q45378512 | ||
| The dominance of China 1 in the spectrum of Epstein-Barr virus strains from Cantonese patients with nasopharyngeal carcinoma | Q45384135 | ||
| The evolution of Epstein-Barr virus inferred from the conservation and mutation of the virus glycoprotein gp350/220 gene | Q45387202 | ||
| Widespread sequence variation in Epstein-Barr virus nuclear antigen 1 influences the antiviral T cell response | Q45395772 | ||
| Selected amino acid change encoding Epstein-Barr virus-specific T cell epitope of the LMP2A gene in Japanese nasal NK/T cell lymphoma patients | Q45401472 | ||
| Epstein Barr virus genotypes and LMP-1 variants in HIV-infected patients. | Q45407055 | ||
| Polymorphism of C-terminal activation region 2 of Epstein-Barr virus latent membrane protein 1 in predicting distant failure and post-metastatic survival in patients with nasopharyngeal carcinoma. | Q45410136 | ||
| Lineage structures in the genome sequences of three Epstein-Barr virus strains | Q45410258 | ||
| The 30-bp deletion of Epstein-Barr virus latent membrane protein-1 gene has no effect in nasopharyngeal carcinoma. | Q45418181 | ||
| The genome of Epstein-Barr virus type 2 strain AG876. | Q45419603 | ||
| Characterization of Epstein-Barr virus Type I variants based on linked polymorphism among EBNA3A, -3B, and -3C genes | Q45420931 | ||
| A prospective follow-up of Epstein-Barr virus LMP1 genotypes in saliva and blood during infectious mononucleosis. | Q45422527 | ||
| Association of a distinctive strain of Epstein-Barr virus with gastric cancer. | Q45423366 | ||
| Epstein-barr virus (EBV) in healthy carriers: Distribution of genotypes and 30 bp deletion in latent membrane protein-1 (LMP-1) oncogene. | Q45621455 | ||
| Amino acid changes in functional domains of latent membrane protein 1 of Epstein-Barr virus in nasopharyngeal carcinoma of southern China and Taiwan: prevalence of an HLA A2-restricted 'epitope-loss variant'. | Q45622728 | ||
| V-val subtype of Epstein-Barr virus nuclear antigen 1 preferentially exists in biopsies of nasopharyngeal carcinoma | Q45627981 | ||
| Sequence variations of Epstein-Barr virus LMP2A gene in gastric carcinoma in Japan | Q45746583 | ||
| Signal transduction from the Epstein-Barr virus LMP-1 transforming protein | Q45755742 | ||
| An Epstein-Barr virus anti-apoptotic protein constitutively expressed in transformed cells and implicated in burkitt lymphomagenesis: the Wp/BHRF1 link | Q21131584 | ||
| Genetic editing of herpes simplex virus 1 and Epstein-Barr herpesvirus genomes by human APOBEC3 cytidine deaminases in culture and in vivo | Q24305160 | ||
| Compartmentalization and transmission of multiple epstein-barr virus strains in asymptomatic carriers | Q24541318 | ||
| Epstein-Barr virus (EBV) nuclear antigen (EBNA)-4 mutation in EBV-associated malignancies in three different populations | Q24670596 | ||
| Epstein-barr virus sequence variation-biology and disease | Q27003183 | ||
| Genetic diversity of EBV-encoded LMP1 in the Swiss HIV Cohort Study and implication for NF-Κb activation | Q28731826 | ||
| Specific capture and whole-genome sequencing of viruses from clinical samples | Q28742542 | ||
| Isolation and sequencing of the Epstein-Barr virus BNLF-1 gene (LMP1) from a Chinese nasopharyngeal carcinoma | Q33248430 | ||
| Genome rearrangements activate the Epstein-Barr virus gene whose product disrupts latency | Q33688737 | ||
| Vaccine strategies against Epstein-Barr virus-associated diseases: lessons from studies on cytotoxic T-cell-mediated immune regulation | Q33776109 | ||
| Epstein-Barr virus WZhet DNA can induce lytic replication in epithelial cells in vitro, although WZhet is not detectable in many human tissues in vivo | Q33832940 | ||
| A cohort study among university students: identification of risk factors for Epstein-Barr virus seroconversion and infectious mononucleosis | Q33997176 | ||
| C-terminal region of EBNA-2 determines the superior transforming ability of type 1 Epstein-Barr virus by enhanced gene regulation of LMP-1 and CXCR7. | Q33998709 | ||
| Unexpected instability of family of repeats (FR), the critical cis-acting sequence required for EBV latent infection, in EBV-BAC systems. | Q34082799 | ||
| Conserved mutation of Epstein-Barr virus-encoded BamHI-A Rightward Frame-1 (BARF1) gene in Indonesian nasopharyngeal carcinoma | Q34173615 | ||
| Sequence variations of latent membrane protein 2A in Epstein-Barr virus-associated gastric carcinomas from Guangzhou, southern China | Q34217852 | ||
| Genomic sequence analysis of Epstein-Barr virus strain GD1 from a nasopharyngeal carcinoma patient | Q34228526 | ||
| DNA sequence and expression of the B95-8 Epstein-Barr virus genome. | Q34245077 | ||
| Genomic diversity of Epstein-Barr virus genomes isolated from primary nasopharyngeal carcinoma biopsy samples. | Q34262322 | ||
| Genomic sequencing and comparative analysis of Epstein-Barr virus genome isolated from primary nasopharyngeal carcinoma biopsy. | Q34271121 | ||
| Epstein-Barr virus nuclear protein 2 is a key determinant of lymphocyte transformation | Q34324039 | ||
| Sequence analysis of the Epstein-Barr virus (EBV) BRLF1 gene in nasopharyngeal and gastric carcinomas | Q34410536 | ||
| Variations of Epstein-Barr virus nuclear antigen 1 in Epstein-Barr virus-associated gastric carcinomas from Guangzhou, southern China | Q34493991 | ||
| Epstein-Barr virus: transformation, cytopathic changes, and viral antigens in squirrel monkey and marmoset leukocytes | Q34688308 | ||
| LMP1 strain variants: biological and molecular properties. | Q34717145 | ||
| The Epstein-Barr virus encoded BART miRNAs potentiate tumor growth in vivo | Q34973323 | ||
| Multiple Epstein-Barr Virus Infections in Healthy Individuals | Q34997005 | ||
| Identification and characterization of EBV genomes in spontaneously immortalized human peripheral blood B lymphocytes by NGS technology | Q35046901 | ||
| Epstein-Barr virus type 2 latently infects T cells, inducing an atypical activation characterized by expression of lymphotactic cytokines. | Q35115666 | ||
| A major EBNA1 variant from Asian EBV isolates shows enhanced transcriptional activity compared to prototype B95.8. | Q40032608 | ||
| Difference of Epstein-Barr virus isolates from Japanese patients and African Burkitt's lymphoma cell lines based on the sequence of latent membrane protein 1. | Q40242249 | ||
| Clonality analysis by sequence variation of the latent membrane protein 1 gene in patients with chronic active Epstein-Barr virus infection. | Q40289516 | ||
| Functional assays of HLA A2-restricted epitope variant of latent membrane protein 1 (LMP-1) of Epstein-Barr virus in nasopharyngeal carcinoma of Southern China and Taiwan | Q40347874 | ||
| Nucleotide sequences and functions of the Epstein-Barr virus latent membrane protein 1 genes isolated from salivary gland lymphoepithelial carcinomas. | Q40451327 | ||
| Selection pressure-driven evolution of the Epstein-Barr virus-encoded oncogene LMP1 in virus isolates from Southeast Asia | Q40545923 | ||
| Updated Epstein-Barr virus (EBV) DNA sequence and analysis of a promoter for the BART (CST, BARF0) RNAs of EBV. | Q40585890 | ||
| Epstein-Barr virus-associated Burkitt lymphomagenesis selects for downregulation of the nuclear antigen EBNA2. | Q40705440 | ||
| DNA sequence heterogeneity within the Epstein-Barr virus family of repeats in the latent origin of replication. | Q40820313 | ||
| Characterization of variants in the promoter of BZLF1 gene of EBV in nonmalignant EBV-associated diseases in Chinese children | Q40835517 | ||
| The major immunogenic epitopes of Epstein-Barr virus (EBV) nuclear antigen 1 are encoded by sequence domains which vary among nasopharyngeal carcinoma biopsies and EBV-associated cell lines | Q40967833 | ||
| Are particular Epstein-Barr virus strains linked to disease? | Q41246845 | ||
| Antigenic and sequence variation in the C-terminal unique domain of the Epstein-Barr virus nuclear antigen EBNA-1. | Q41349686 | ||
| Human cytotoxic T lymphocyte responses to Epstein-Barr virus infection | Q41464315 | ||
| Epstein-Barr virus (EBV)-associated lymphoproliferative disease in the SCID mouse model: implications for the pathogenesis of EBV-positive lymphomas in man | Q41704288 | ||
| Sequence and transcription of Raji Epstein-Barr virus DNA spanning the B95-8 deletion region | Q41716583 | ||
| Epstein-Barr virus BZLF1 gene polymorphisms: malignancy related or geographically distributed variants? | Q42222365 | ||
| Sequence analysis of EBV immediate-early gene BZLF1 and BRLF1 in lymphomas. | Q42232463 | ||
| Spontaneous lytic replication and epitheliotropism define an Epstein-Barr virus strain found in carcinomas | Q42262852 | ||
| Impact of Epstein-Barr virus load, virus genotype, and frequency of the 30 bp deletion in the viral BNLF-1 gene in patients harboring the human immunodeficiency virus | Q42271409 | ||
| Epstein-barr virus latent membrane protein 1 polymorphism in nasopharyngeal carcinoma and other oral cavity tumors in Russia | Q42271849 | ||
| LMP1 promoter sequence analysis in Epstein Barr virus pediatric infection reveals preferential circulation of B95.8 related variants in Argentina | Q42279313 | ||
| Epstein-Barr virus gene polymorphism in different parts of the same nasopharyngeal carcinoma patient | Q43410058 | ||
| Detection of Epstein-Barr virus and genotyping based on EBNA2 protein in Mexican patients with hodgkin lymphoma: a comparative study in children and adults | Q43729091 | ||
| Multiple Epstein-Barr virus strains in patients with infectious mononucleosis: comparison of ex vivo samples with in vitro isolates by use of heteroduplex tracking assays | Q43860728 | ||
| Biology of Epstein-Barr virus during infectious mononucleosis | Q43971482 | ||
| Evidence for trafficking of Epstein-Barr virus strains between hairy leukoplakia and peripheral blood lymphocytes | Q44261604 | ||
| Carboxyl-terminal sequence variation of latent membrane protein 1 gene in Epstein-Barr virus-associated gastric carcinomas from Eastern China and Japan | Q44369687 | ||
| Epstein-Barr virus genotypes and strains in central nervous system demyelinating disease and Epstein-Barr virus-related illnesses in Australia. | Q44757734 | ||
| Epstein-Barr virus strains defined by the latent membrane protein 1 sequence characterize Thai ethnic groups | Q44775743 | ||
| Persistence and transition of Epstein-Barr virus genotypes in the pathogenesis of oral hairy leukoplakia | Q44951056 | ||
| Characterization of Epstein-Barr virus (EBV) BZLF1 gene promoter variants and comparison of cellular gene expression profiles in Japanese patients with infectious mononucleosis, chronic active EBV infection, and EBV-associated hemophagocytic lymphoh | Q45358262 | ||
| Unique variations of Epstein-Barr virus-encoded BARF1 gene in nasopharyngeal carcinoma biopsies | Q45359052 | ||
| Carboxy-terminal sequence variation of LMP1 gene in Epstein-Barr-virus-associated mononucleosis and tumors from Serbian patients. | Q45359636 | ||
| Characterization of Epstein-Barr virus type 1 nuclear antigen 3C sequence patterns of nasopharyngeal and gastric carcinomas in northern China | Q45359935 | ||
| A recombinant modified vaccinia ankara vaccine encoding Epstein-Barr Virus (EBV) target antigens: a phase I trial in UK patients with EBV-positive cancer | Q35121627 | ||
| Ex vivo analysis of T-cell responses to Epstein-Barr virus-encoded oncogene latent membrane protein 1 reveals highly conserved epitope sequences in virus isolates from diverse geographic regions. | Q35149684 | ||
| Direct sequencing and characterization of a clinical isolate of Epstein-Barr virus from nasopharyngeal carcinoma tissue by using next-generation sequencing technology | Q35363383 | ||
| Epstein-Barr virus BamHI W repeat number limits EBNA2/EBNA-LP coexpression in newly infected B cells and the efficiency of B-cell transformation: a rationale for the multiple W repeats in wild-type virus strains | Q35531692 | ||
| Characteristics of epstein barr virus variants associated with gastric carcinoma in Southern Tunisia | Q35550673 | ||
| Epstein-Barr virus (EBV) subtype in EBV related oral squamous cell carcinoma in Okinawa, a subtropical island in southern Japan, compared with Kitakyushu and Kumamoto in mainland Japan | Q35586187 | ||
| Genome diversity of Epstein-Barr virus from multiple tumor types and normal infection | Q35641421 | ||
| Epstein-Barr virus isolates retain their capacity to evade T cell immunity through BNLF2a despite extensive sequence variation | Q35665981 | ||
| Analysis of EBNA-1 and LMP-1 variants in diseases associated with EBV infection in Chinese children | Q35717137 | ||
| Molecular cloning of the complete Epstein-Barr virus genome as a set of overlapping restriction endonuclease fragments | Q35739385 | ||
| A defective, rearranged Epstein-Barr virus genome in EBER-negative and EBER-positive Hodgkin's disease | Q35788728 | ||
| Distinctive Epstein-Barr virus variants associated with benign and malignant pediatric pathologies: LMP1 sequence characterization and linkage with other viral gene polymorphisms | Q35807158 | ||
| Sequence analysis of Epstein-Barr virus EBNA-2 gene coding amino acid 148-487 in nasopharyngeal and gastric carcinomas. | Q35854314 | ||
| EBNA3B-deficient EBV promotes B cell lymphomagenesis in humanized mice and is found in human tumors | Q35858022 | ||
| Epstein-Barr virus: an important vaccine target for cancer prevention | Q36408680 | ||
| Epstein-Barr virus latent membrane protein-1 (LMP-1) 30-bp deletion and Xho I-loss is associated with type III nasopharyngeal carcinoma in Malaysia | Q36492355 | ||
| Whole-genome sequencing of the Akata and Mutu Epstein-Barr virus strains | Q36559612 | ||
| Potential selection of LMP1 variants in nasopharyngeal carcinoma | Q36944141 | ||
| Tumor-derived variants of Epstein-Barr virus latent membrane protein 1 induce sustained Erk activation and c-Fos | Q37021555 | ||
| Evolution and diversity in human herpes simplex virus genomes | Q37547447 | ||
| U2 region of Epstein-Barr virus DNA may encode Epstein-Barr nuclear antigen 2 | Q37579511 | ||
| Co-infections, inflammation and oncogenesis: future directions for EBV research | Q38206054 | ||
| High frequency of latent membrane protein-1 30-bp deletion variant with specific single mutations in Epstein-Barr virus-associated nasopharyngeal carcinoma in Moroccan patients | Q38961888 | ||
| A single amino acid in EBNA-2 determines superior B lymphoblastoid cell line growth maintenance by Epstein-Barr virus type 1 EBNA-2. | Q38992835 | ||
| Various 30 and 69 bp deletion variants of the Epstein-Barr virus LMP1 may arise by homologous recombination in nasopharyngeal carcinoma of Tunisian patients | Q39040021 | ||
| Complete genomic sequence of Epstein-Barr virus in nasopharyngeal carcinoma cell line C666-1. | Q39115333 | ||
| Novel intertypic recombinants of epstein-barr virus in the chinese population | Q39588391 | ||
| Biophysical analysis of natural variants of the multimerization region of Epstein-Barr virus lytic-switch protein BZLF1. | Q39606252 | ||
| Identification of Epstein-Barr virus strain variants in hairy leukoplakia and peripheral blood by use of a heteroduplex tracking assay | Q39684889 | ||
| Functionally significant mutations in the Epstein-Barr virus LMP1 gene and their role in activation of cell signaling pathways. | Q39920117 | ||
| Epstein-Barr virus genetic variation in Vietnamese patients with nasopharyngeal carcinoma: full-length analysis of LMP1. | Q39956324 | ||
| Differential gene regulation by Epstein-Barr virus type 1 and type 2 EBNA2. | Q39982347 | ||
| HLA-A11-restricted epitope polymorphism among Epstein-Barr virus strains in the highly HLA-A11-positive Chinese population: incidence and immunogenicity of variant epitope sequences. | Q40011740 | ||
| Latent gene sequencing reveals familial relationships among Chinese Epstein-Barr virus strains and evidence for positive selection of A11 epitope changes | Q40011755 | ||
| P433 | issue | Pt 1 | |
| P921 | main subject | Epstein–Barr virus | Q6900 |
| P304 | page(s) | 45-69 | |
| P577 | publication date | 2015-01-01 | |
| P1433 | published in | Current Topics in Microbiology and Immunology | Q15752446 |
| P1476 | title | Epstein-Barr Virus Strain Variation | |
| P478 | volume | 390 |
| Q40375637 | Carcinoma-risk variant of EBNA1 deregulates Epstein-Barr Virus episomal latency. |
| Q53822207 | Construction and Characterization of a Humanized Anti-Epstein-Barr Virus gp350 Antibody with Neutralizing Activity in Cell Culture. |
| Q39016336 | Current Trends and Alternative Scenarios in EBV Research |
| Q64901933 | Efficient Epstein-Barr Virus Progeny Production Mediated by Cancer-Derived LMP1 and Virally-Encoded microRNAs. |
| Q38833222 | Epigenetics and Genetics of Viral Latency |
| Q40046633 | Epstein-Barr virus infection and nasopharyngeal carcinoma |
| Q64118196 | Epstein-Barr virus strain variation and cancer |
| Q55312268 | Epstein–Barr Virus Epidemiology, Serology, and Genetic Variability of LMP-1 Oncogene Among Healthy Population: An Update. |
| Q90148663 | First Days in the Life of Naive Human B Lymphocytes Infected with Epstein-Barr Virus |
| Q36812001 | Highly Efficient CRISPR/Cas9-Mediated Cloning and Functional Characterization of Gastric Cancer-Derived Epstein-Barr Virus Strains |
| Q33907682 | Natural Variation of Epstein-Barr Virus Genes, Proteins, and Primary MicroRNA. |
| Q59351223 | Natural Variations in BRLF1 Promoter Contribute to the Elevated Reactivation Level of Epstein-Barr Virus in Endemic Areas of Nasopharyngeal Carcinoma |
| Q45323519 | Prevalence and molecular profiling of Epstein Barr virus (EBV) among healthy blood donors from different nationalities in Qatar |
| Q56895491 | The Role of aDNA in Understanding the Coevolutionary Patterns of Human Sexually Transmitted Infections |
Search more.